Stock OCX ONCOCYTE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart OncoCyte Corporation

Equities

OCX

US68235C2061

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
2.907 USD +3.07% Intraday chart for OncoCyte Corporation -1.47% +16.26%
May. 15 Transcript : OncoCyte Corporation, Q1 2024 Earnings Call, May 15, 2024
May. 15 Earnings Flash (OCX) ONCOCYTE CORPORATION Reports Q1 Revenue $176,000, vs. Street Est of $0.4M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ONCOCYTE CORPORATION
Bio Therapeutic Drugs
+3.07%-1.47%+16.26%-38.45%-97.06% 38.85M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. OCX Stock
  4. Charts OncoCyte Corporation
  5. Comparison Chart